Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen Yangxue Prescription for Prevention and Treatment of Unexplained Recurrent Spontaneous Abortion
ChiCTR2400092011Phase 4Recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of bushen huoxue in recurrent miscarriage (RPL) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Change in TCM symptom scores, Effective pregnancy rate and 1 more. Started Nov 2024; status: recruiting.
02
Drugs
bushen huoxue
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR2400092011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092011.